Lemonade, Inc. (NYSE:LMND) COO Adina Eckstein Sells 23,644 Shares of Stock

Lemonade, Inc. (NYSE:LMND) COO Adina Eckstein sold 23,644 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $50.00, for a total transaction of $1,182,200.00. Following the transaction, the chief operating officer now owns 189,653 shares of the company’s stock, valued at approximately $9,482,650. This trade represents a 11.09 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Adina Eckstein also recently made the following trade(s):

• On Tuesday, November 19th, Adina Eckstein sold 23,644 shares of Lemonade stock. The shares were sold at an average price of $40.00, for a total value of $945,760.00.

Lemonade Stock Down 4.5 %

Lemonade stock traded down $2.29 during mid-day trading on Friday, hitting $48.07. The company had a trading volume of 1,639,569 shares, compared to its average volume of 1,756,962. The business has a fifty day moving average of $22.36 and a 200 day moving average of $19.29. Lemonade, Inc. has a 1 year low of $14.03 and a 1 year high of $52.22. The stock has a market cap of $3.43 billion, a price-to-earnings ratio of -16.57 and a beta of 1.68.

Lemonade (NYSE:LMND) last released its quarterly earnings data on Wednesday, October 30th. The company reported ($0.95) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.02) by $0.07. Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. The company had revenue of $136.60 million during the quarter, compared to the consensus estimate of $129.10 million. During the same quarter in the prior year, the firm posted ($0.88) earnings per share. Lemonade’s revenue for the quarter was up 19.3% on a year-over-year basis. Equities analysts anticipate that Lemonade, Inc. will post -3.05 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Jefferies Financial Group dropped their target price on shares of Lemonade from $15.00 to $14.00 and set an “underperform” rating on the stock in a research report on Wednesday, October 9th. Piper Sandler upped their target price on shares of Lemonade from $25.00 to $44.00 and gave the company a “neutral” rating in a research report on Thursday. Morgan Stanley upgraded shares of Lemonade from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $23.00 to $42.00 in a report on Wednesday. Keefe, Bruyette & Woods lowered Lemonade from a “market perform” rating to an “underperform” rating and raised their price target for the stock from $18.00 to $21.00 in a research report on Thursday, November 7th. Finally, JMP Securities raised their target price on Lemonade from $40.00 to $60.00 and gave the company a “market outperform” rating in a report on Friday. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $30.43.

Institutional Investors Weigh In On Lemonade

Several hedge funds have recently made changes to their positions in LMND. Axiom Advisory LLC increased its position in Lemonade by 1.6% in the 3rd quarter. Axiom Advisory LLC now owns 54,400 shares of the company’s stock valued at $897,000 after acquiring an additional 850 shares during the period. Blue Trust Inc. increased its holdings in shares of Lemonade by 220.0% in the third quarter. Blue Trust Inc. now owns 2,733 shares of the company’s stock valued at $45,000 after purchasing an additional 1,879 shares during the period. Van ECK Associates Corp raised its stake in shares of Lemonade by 12.1% during the second quarter. Van ECK Associates Corp now owns 17,774 shares of the company’s stock worth $293,000 after purchasing an additional 1,915 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Lemonade by 9.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 24,609 shares of the company’s stock worth $404,000 after purchasing an additional 2,196 shares during the period. Finally, The Manufacturers Life Insurance Company grew its position in Lemonade by 9.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 29,194 shares of the company’s stock valued at $482,000 after buying an additional 2,582 shares during the last quarter. Institutional investors and hedge funds own 80.30% of the company’s stock.

About Lemonade

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.